Giapreza
NDC 68547-501, angiotensin II, injection, from La Jolla Pharmaceutical Company.
- Product NDC
- 68547-501
- Status
- Listed
- Labeler
- La Jolla Pharmaceutical Company
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209360
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68547-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANGIOTENSIN II2.5 mg/mL
Pharmacologic classes
Vasoconstriction [PE]; Vasoconstrictor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68547-501-02 | 68547050102 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-02) / 1 mL in 1 VIAL, SINGLE-DOSE |
| 68547-501-07 | 68547050107 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-07) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c265d69a-3efe-4107-9a9e-e6fd3d531c48
Use it
Look up 68547-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68547-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68547-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.